Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery

Oncology Reports

Volumn 37, Issue 2, 2017, Pages 937-944

  Bin, Zhang ^a   Yueying, Zhang ^b   Yu, Dongmei ^a  

^a First People's Hospital of Jining   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Dual liganddecorated; Gene therapy; Hyaluronic acid; Lipid carriers; Lung cancer; Transferrin

Indexed keywords

DISTEAROYLPHOSPHATIDYLETHANOLAMINE; ETHANOLAMINE DERIVATIVE; HYALURONIC ACID; MACROGOL; NANOCARRIER; PLASMID DNA; TRANSFERRIN; UNCLASSIFIED DRUG; DNA; DRUG CARRIER; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; MACROGOL DERIVATIVE; MESSENGER RNA; NANOMATERIAL; PHOSPHATIDYLETHANOLAMINE; POLYETHYLENE GLYCOL-DISTEAROYLPHOSPHATIDYLETHANOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; CANCER GENE THERAPY; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; IONIC STRENGTH; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PLASMID; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ADENOCARCINOMA; ADMINISTRATION AND DOSAGE; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CELL PROLIFERATION; CHEMISTRY; DRUG SCREENING; GENE THERAPY; GENE TRANSFER; GENETICS; LUNG NEOPLASMS; METABOLISM; NUDE MOUSE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; DNA; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; HYALURONIC ACID; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOSTRUCTURES; PHOSPHATIDYLETHANOLAMINES; PLASMIDS; POLYETHYLENE GLYCOLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TRANSFERRIN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85011900734     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2016.5298     Document Type: Article

References (42)

1. Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64: 9-29, 2014.
2. Poulsen TT, Pedersen N and Poulsen HS: Replacement and suicide gene therapy for targeted treatment of lung cancer. Clin Lung Cancer 6: 227-236, 2005.
3. Stuckey DW and Shah K: Stem cell-based therapies for cancer treatment: Separating hope from hype. Nat Rev Cancer 14: 683-691, 2014.
4. Zhang TY, Huang B, Wu HB, Wu JH, Li LM, Li YX, Hu YL, Han M, Shen YQ, Tabata Y, et al: Synergistic effects of co-administration of suicide gene expressing mesenchymal stem cells and prodrug-encapsulated liposome on aggressive lung melanoma metastases in mice. J Control Release 209: 260-271, 2015.
5. Cho WY, Hong SH, Singh B, Islam MA, Lee S, Lee AY, Gankhuyag N, Kim JE, Yu KN, Kim KH, et al: Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA. Eur J Pharm Biopharm 94: 450-462, 2015.
6. Kim I, Byeon HJ, Kim TH, Lee ES, Oh KT, Shin BS, Lee KC and Youn YS: Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer. Biomaterials 34: 6444-6453, 2013.
7. Merdan T, Kopecek J and Kissel T: Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev 54: 715-758, 2002.
8. Xie RL, Jang YJ, Xing L, Zhang BF, Wang FZ, Cui PF, Cho MH and Jiang HL: A novel potential biocompatible hyperbranched polyspermine for efficient lung cancer gene therapy. Int J Pharm 478: 19-30, 2015.
9. Christensen CL, Zandi R, Gjetting T, Cramer F and Poulsen HS: Specifically targeted gene therapy for small-cell lung cancer. Expert Rev Anticancer Ther 9: 437-452, 2009.
10. Chen Y, Gao DY and Huang L: In vivo delivery of miRNAs for cancer therapy: Challenges and strategies. Adv Drug Deliv Rev 81: 128-141, 2015.
11. Chen Y, Zhu X, Zhang X, Liu B and Huang L: Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther 18: 1650-1656, 2010.
12. Lennox KA and Behlke MA: Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther 18: 1111-1120, 2011.
13. Tivnan A, Orr WS, Gubala V, Nooney R, Williams DE, McDonagh C, Prenter S, Harvey H, Domingo-Fernández R, Bray IM, et al: Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles. PLoS One 7: e38129, 2012.
14. Heger Z, Gumulec J, Cernei N, Tmejova K, Kopel P, Balvan J, Masarik M, Zitka O, Beklova M, Adam V, et al: 17β-estradiolcontaining liposomes as a novel delivery system for the antisense therapy of ER-positive breast cancer: An in vitro study on the MCF-7 cell line. Oncol Rep 33: 921-9, 2015.
15. de Jesus MB and Zuhorn IS: Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanisms. J Control Release 201: 1-13, 2015.
16. Zhang Z, Sha X, Shen A, Wang Y, Sun Z, Gu Z and Fang X: Polycation nanostructured lipid carrier, a novel nonviral vector constructed with triolein for efficient gene delivery. Biochem Biophys Res Commun 370: 478-482, 2008.
17. Doktorovova S, Souto EB and Silva AM: Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers-a systematic review of in vitro data. Eur J Pharm Biopharm 87: 1-18, 2014.
18. Han Y, Zhang Y, Li D, Chen Y, Sun J and Kong F: Transferrinmodified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin. Int J Nanomed 9: 4107-4116, 2014.
19. Avitabile T, Marano F, Castiglione F, Bucolo C, Cro M, Ambrosio L, Ferrauto C and Reibaldi A: Biocompatibility and biodegradation of intravitreal hyaluronan implants in rabbits. Biomaterials 22: 195-200, 2001.
20. Fang XJ, Jiang H, Zhu YQ, Zhang LY, Fan QH and Tian Y: Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells. Oncol Rep 31: 2735-2742, 2014.
21. Coradini D, Pellizzaro C, Abolafio G, Bosco M, Scarlata I, Cantoni S, Stucchi L, Zorzet S, Turrin C, Sava G, et al: Hyaluronic-acid butyric esters as promising antineoplastic agents in human lung carcinoma: A preclinical study. Invest New Drugs 22: 207-217, 2004.
22. Pan J, Sun SK, Wang Y, Fu YY, Zhang X, Zhang Y and Yu C: Facile preparation of hyaluronic acid and transferrin co-modified Fe3O4 nanoparticles with inherent biocompatibility for dualtargeting magnetic resonance imaging of tumors in vivo. Dalton Trans 44: 19836-19843, 2015.
23. Kondo H, Miyoshi K, Sakiyama S, Tangoku A and Noma T: Differential regulation of gene expression of alveolar epithelial cell markers in human lung adenocarcinoma-derived A549 clones. Stem Cells Int 2015: 165867, 2015.
24. Wang W, Zhou F, Ge L, Liu X and Kong F: Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. Int J Nanomed 7: 2513-2522, 2012.
25. Jing L, Shao S, Wang Y, Yang Y, Yue X and Dai Z: Hyaluronic acid modified hollow Prussian blue nanoparticles loading 10-hydroxycamptothecin for targeting thermochemotherapy of cancer. Theranostics 6: 40-53, 2016.
26. Zhang XG, Miao J, Dai YQ, Du YZ, Yuan H and Hu FQ: Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells. Int J Pharm 361: 239-244, 2008.
27. Du YZ, Cai LL, Li J, Zhao MD, Chen FY, Yuan H and Hu FQ: Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles. Int J Nanomed 6: 1559-1568, 2011.
28. Yu W, Liu C, Liu Y, Zhang N and Xu W: Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res 27: 1584-1596, 2010.
29. Wang RH, Cao HM, Tian ZJ, Jin B, Wang Q, Ma H and Wu J: Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer. Oncol Rep 33: 783-791, 2015.
30. Yu W, Liu C, Ye J, Zou W, Zhang N and Xu W: Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery. Nanotechnology 20: 215102, 2009.
31. Pepić I, Lovrić J, Hafner A and Filipović-Grčić J: Powder form and stability of Pluronic mixed micelle dispersions for drug delivery applications. Drug Dev Ind Pharm 40: 944-951, 2014.
32. Yu X, Yang G, Shi Y, Su C, Liu M, Feng B and Zhao L: Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance. Int J Nanomed 10: 7045-7056, 2015.
33. Zou W, Liu C, Chen Z and Zhang N: Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancer. Int J Pharm 370: 187-195, 2009.
34. Vighi E, Montanari M, Hanuskova M, Iannuccelli V, Coppi G and Leo E: Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector. Int J Pharm 440: 161-169, 2013.
35. Hazzah HA, Farid RM, Nasra MM, El-Massik MA and Abdallah OY: Lyophilized sponges loaded with curcumin solid lipid nanoparticles for buccal delivery: Development and characterization. Int J Pharm 492: 248-257, 2015.
36. Wang L, Dong J, Ouyang W, Wang X and Tang J: Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles. Oncol Rep 27: 719-726, 2012.
37. Ravi Kumar MN, Bakowsky U and Lehr CM: Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 25: 1771-1777, 2004.
38. Immordino ML, Brusa P, Rocco F, Arpicco S, Ceruti M and Cattel L: Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. J Control Release 100: 331-346, 2004.
39. Song RF, Li XJ, Cheng XL, Fu AR, Wang YH, Feng YJ and Xiong Y: Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors. Oncol Rep 32: 1481-1488, 2014.
40. Torchilin VP: Multifunctional nanocarriers. Adv Drug Deliv Rev 58: 1532-1555, 2006.
41. Kamiya H, Tsuchiya H, Yamazaki J and Harashima H: Intracellular trafficking and transgene expression of viral and non-viral gene vectors. Adv Drug Deliv Rev 52: 153-164, 2001.
42. Jiang HL, Hong SH, Kim YK, Islam MA, Kim HJ, Choi YJ, Nah JW, Lee KH, Han KW, Chae C, et al: Aerosol delivery of spermine-based poly(amino ester)/Akt1 shRNA complexes for lung cancer gene therapy. Int J Pharm 420: 256-265, 2011.